Oaktree Acquisition (OAC) Short Interest Ratio & Short Volume

Short interest is the volume of Oaktree Acquisition shares that have been sold short but have not yet been closed out or covered. As of December 31st, traders have sold 76,300 shares of OAC short. 0.39% of Oaktree Acquisition's shares are currently sold short. Learn More on Oaktree Acquisition's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.39% of Oaktree Acquisition's floating shares are currently sold short.

Oaktree Acquisition saw a decrease in short interest during the month of December. As of December 31st, there was short interest totaling 76,300 shares, a decrease of 43.9% from the previous total of 136,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Oaktree Acquisition currently has issued a total of 25,156,000 shares. Some of Oaktree Acquisition's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Oaktree Acquisition currently has a public float of 19,620,000 shares.

0.39% of Oaktree Acquisition's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Oaktree Acquisition: LifeMD, Inc. (7.47%), Neoleukin Therapeutics, Inc. (0.35%), MeiraGTx Holdings plc (1.77%), Viemed Healthcare, Inc. (1.18%), Nautilus Biotechnology, Inc. (1.95%), Clover Health Investments, Corp. (9.72%), Atea Pharmaceuticals, Inc. (2.37%), Rani Therapeutics Holdings, Inc. (14.69%), Organogenesis Holdings Inc. (10.76%), Lyra Therapeutics, Inc. (0.55%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($6.95 billion), Aon plc ($4.44 billion), Analog Devices, Inc. ($4.13 billion), Snap Inc. ($3.12 billion), Peloton Interactive, Inc. ($2.68 billion), Moderna, Inc. ($2.60 billion), The Clorox Company ($2.47 billion), The Kroger Co. ($2.32 billion), International Flavors & Fragrances Inc. ($2.21 billion), and Altice USA, Inc. ($1.94 billion). View all of the most shorted stocks.

Short selling OAC is an investing strategy that aims to generate trading profit from Oaktree Acquisition as its price is falling. OAC shares are trading down $0.98 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Oaktree Acquisition occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OAC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OAC, twice per month. The most recent reporting period available is December, 31 2020.